Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer | NEJM – nejm.org June 3, 2023
AstraZeneca: Tagrisso-chemo combo improved progression-free survival in late-stage lung cancer trial – Endpoints News – Endpoints News May 17, 2023
Tagrisso plus chemotherapy demonstrated strong improvement in progression-free survival for patients with EGFR-mutated advanced lung cancer in FLAURA2 Phase III trial – AstraZeneca May 17, 2023
Merck Announces Phase 3 KEYNOTE-671 Trial Met Primary Endpoint of Event-Free Survival (EFS) in Patients With Resectable Stage II, IIIA or IIIB Non-Small Cell Lung Cancer – Merck March 1, 2023
Vaping CBD causes more severe lung damage than vaping nicotine, new study shows – Medical Xpress February 27, 2023
Lung cancer survival rate: Symptoms and myths everyone needs to stop believing November 25, 2022November 25, 2022